Dr. Freek Verheugt Presents: ACC 2019 Wrap-Up from the Perspective of the Netherlands March 18, 2019 Disclosures: TBA
Dr. Sanjiv Shah and Dr. Yazan Daaboul Discuss: PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial March 18, 2019 Disclosures: TBA
Dr. Manesh Patel and Dr. C. Michael Gibson Discuss: ADVANCE Registry: Impact of FFRCT on 1-Year Outcomes in Patients Evaluated: Lessons from the ADVANCE Registry March 18, 2019 Disclosures: TBA
Dr. Allen Jeremias and Dr. C. Michael Gibson Discuss: The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention March 18, 2019 Disclosures: TBA
Dr. Martin Leon and Dr. C. Michael Gibson Discuss: PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results of the PARTNER 3 Trial March 18, 2019 Disclosures: TBA
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: AUGUSTUS Trial: An Open-label, 2 x 2 Factorial, Randomized Trial to Evaluate the Safety of Apixaban versus Vitamin K Antagonist and Aspirin versus Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention: Primary Results of the AUGUSTUS Trial March 18, 2019 Disclosures: TBA
Dr. Wilson Mathias and Dr. Yazan Daaboul Dicuss: MRUSMI: Sonothrombolysis in ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: Final Results from the First Randomized Study in Humans March 18, 2019 Disclosures: TBA
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: ACC 2019 Daily Wrap-Up – Monday, March 18, 2019 March 18, 2019 Disclosures: TBA
